The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)
Issues
Latest issue
Regular issues
Supplements
PCR Trials
All issues
Articles
Regular articles
Ahead of print
All articles
Topics
Coronary interventions
STEMI
NSTEMI
Stable CAD
Stents and scaffolds
Left main and multivessel disease
Bifurcation lesions
CTO
Other coronary interventions
Interventions for valvular disease
TAVI
Mitral valve replacement and repair
Tricuspid / Pulmonary valve
Other valvular and structural interventions
Interventions for heart failure
Acute heart failure
Chronic heart failure
Peripheral interventions
Below the knee
Abdominal aortic aneurysm
Iliac / Femoral / Popliteal
Other peripheral interventions
Interventions for hypertension
Renal artery angioplasty
Renal denervation
Other hypertension
Interventions for stroke
Carotid stenting
LAA closure
Ischaemic stroke
Other stroke interventions
News
Services
Subscribe
Advertise
Reprint-Eprint
Join our mailing list
About
Overview
Editorial board
Rights & permissions
Contact us
Author centre
Felix Mahfoud
Showing 1-20 of 31 articles
Renal denervation in the management of hypertension in adults. A clinical consensus statement of the ESC Council on Hypertension and the European Association of Percutaneous Cardiovascular Interventions (EAPCI)
Barbato E,
Azizi M,
Schmieder RE,
Lauder L,
Böhm M,
Brouwers S,
Bruno RM,
Dudek D,
Kahan T,
Kandzari D,
Lüscher T,
Parati G,
Pathak A,
Ribichini F,
Schlaich M,
Sharp A,
Sudano I,
Volpe M,
Tsioufis C,
Wijns W,
Mahfoud F
March 20, 2023 | 10.4244/EIJ-D-22-00723
Translational value of preclinical models for renal denervation: a histological comparison of human versus porcine renal nerve anatomy
Sato Y,
Sharp A,
Mahfoud F,
Tunev S,
Forster A,
Ellis M,
Gomez A,
Dhingra R,
Ullman J,
Schlaich M,
Lee D,
Trudel J,
Hettrick D,
Kandzari D,
Virmani R,
Finn A
February 6, 2023 | 10.4244/EIJ-D-22-00369
Changes in blood pressure after crossover to ultrasound renal denervation in patients initially treated with sham in the RADIANCE-HTN SOLO trial
Mahfoud F,
Bloch M,
Azizi M,
Wang Y,
Schmieder RE,
Lobo M,
Sharp A,
Daemen J,
Basile J,
Weber M,
Scicli A,
McClure C,
Kirtane AJ
December 17, 2021 | 10.4244/EIJ-D-21-00295
Prioritised endpoints for device-based hypertension trials: the win ratio methodology
Kandzari D,
Hickey G,
Pocock S,
Weber M,
Böhm M,
Cohen S,
Fahy M,
Lamberti G,
Mahfoud F
April 2, 2021 | 10.4244/EIJ-D-20-01090
Immediate and long-term impact of the COVID-19 pandemic on cardiovascular clinical trials: considerations for study conduct and endpoint determination
Lansky A,
Shah T,
Wijns W,
Stefanini G,
Farb A,
Kaplan A,
Xu B,
Pietras C,
Velazquez E,
Serruys P,
Mahfoud F,
Baumbach A
November 20, 2020 | 10.4244/EIJV16I10A147
Radiofrequency renal denervation is effective – and safe?
Mahfoud F,
Kulenthiran S
May 20, 2020 | 10.4244/EIJV16I1A4
Bare metal or drug-eluting stent versus drug-coated balloon in non-ST-elevation myocardial infarction: the randomised PEPCAD NSTEMI trial
Scheller B,
Ohlow M,
Ewen S,
Kische S,
Rudolph T,
Clever Y,
Wagner A,
Richter S,
El-Garhy M,
Böhm M,
Degenhardt R,
Mahfoud F,
Lauer B
April 17, 2020 | 10.4244/EIJ-D-19-00723
The AFR-PRELIEVE trial: a prospective, non-randomised, pilot study to assess the Atrial Flow Regulator (AFR) in heart failure patients with either preserved or reduced ejection fraction
Paitazoglou C,
Özdemir R,
Pfister R,
Bergmann M,
Bartunek J,
Kilic T,
Lauten A,
Schmeisser A,
Zoghi M,
Anker S,
Sievert H,
Mahfoud F
August 29, 2019 | 10.4244/EIJ-D-19-00342
Safety and performance of diagnostic electrical mapping of renal nerves in hypertensive patients
Tsioufis C,
Feyz L,
Dimitriadis K,
Konstantinidis D,
Tousoulis D,
Voskuil M,
Mahfoud F,
Daemen J
December 20, 2018 | 10.4244/EIJ-D-18-00536
Will ORBITA change my practice? ORBITA trial: Objective Randomised Blinded Investigation with optimal medical Therapy of Angioplasty in stable angina
Schueler R,
Al-Lamee R,
Mahfoud F,
Capodanno D,
Asnag M,
Haude M
October 19, 2018 | 10.4244/EIJY18M09_2
Evaluating the importance of sham-controlled trials in the investigation of medical devices in interventional cardiology
Byrne R,
Capodanno D,
Mahfoud F,
Fajadet J,
Windecker S,
Jüni P,
Baumbach A,
Wijns W,
Haude M
August 24, 2018 | 10.4244/EIJ-D-18-00481
Will SPYRAL HTN-ON MED change my practice? SPYRAL HTN-ON MED: a prospective, randomised, sham-controlled trial on renal denervation in the presence of antihypertensive medications
Ewen S,
Lauder L,
Azizi M,
Kandzari D,
Pathak A,
Sharif F,
Wijns W,
Mahfoud F,
Lüscher T
August 3, 2018 | 10.4244/EIJY18M07_1
Will SPYRAL HTN-OFF MED change my practice? SPYRAL HTN-OFF MED: a prospective, randomised, sham-controlled trial on renal denervation in the absence of antihypertensive medications
Lauder L,
Ewen S,
Azizi M,
Mauri L,
Lurz P,
Lobo M,
Sharif F,
Wijns W,
Tsioufis C,
Mahfoud F
August 3, 2018 | 10.4244/EIJY18M07_2
Renal artery anatomy assessed by quantitative analysis of selective renal angiography in 1,000 patients with hypertension
Lauder L,
Ewen S,
Tzafriri A,
Edelman E,
Lüscher T,
Blankestijn P,
Dörr O,
Schlaich M,
Sharif F,
Voskuil M,
Zeller T,
Ukena C,
Scheller B,
Böhm M,
Mahfoud F
May 20, 2018 | 10.4244/EIJ-D-18-00112
Renal denervation for treatment of hypertension – will 2017 be the year of enlightenment?
Mahfoud F,
Edelman E
April 7, 2017 | 10.4244/EIJV12I18A355
Will SPRINT change my practice? SPRINT: a randomised trial of intensive versus standard blood-pressure control
Ewen S,
Lobo M,
Pathak A,
Schmieder RE,
Tsioufis C,
Wijns W,
Mahfoud F
August 20, 2016 | 10.4244/EIJV12I6A132
Renal sympathetic nerve denervation using intraluminal ultrasound within a cooling balloon preserves the arterial wall and reduces sympathetic nerve activity
Pathak A,
Coleman L,
Roth A,
Stanley J,
Bailey L,
Markham P,
Ewen S,
Morel C,
Despas F,
Honton B,
Senard J,
Fajadet J,
Mahfoud F
August 20, 2015 | 10.4244/EIJV11I4A96
Renal denervation reloaded: where to go from here?
Mahfoud F,
Serruys P
February 20, 2015 | 10.4244/EIJV10I10A187
From SYMPLICITY HTN-3 to the Renal Denervation Global Registry: where do we stand and where should we go?
Pathak A,
Ewen S,
Fajadet J,
Honton B,
Mahfoud F,
Marco J,
Schlaich M,
Schmieder RE,
Tsioufis C,
Ukena C,
Zeller T
May 20, 2014 | 10.4244/EIJV10I1A4
What the interventionalist should know about renal denervation in hypertensive patients: a position paper by the ESH WG on the interventional treatment of hypertension
Tsioufis C,
Mahfoud F,
Mancia G,
Redon J,
Damascelli B,
Zeller T,
Schmieder RE
January 20, 2014 | 10.4244/EIJV9I9A175
1
2
Latest news
AHEAD OF PRINT
Ostial RCA ISR: mechanisms and treatment outcomes
FREE ARTICLE - Kei Yamamoto et al
June 7, 2023
AHEAD OF PRINT
Two-year outcomes after TMVR
FREE ARTICLE - Sebastian Ludwig et al
May 26, 2023
NEW ISSUE
Expert Review on Calcified CTOs; Calcified Nodules Revascularisation Debate; CTO PCI; Stent Failure and Calcified Nodules and more...
June 5, 2023
AHEAD OF PRINT
BIOSOLVE-IV registry
FREE ARTICLE - Adrian Wlodarczak et al
May 24, 2023
AHEAD OF PRINT EUROPCR
The EURO SHOCK Trial
FREE ARTICLE - Amerjeet Singh Banning et al
May 19, 2023
AHEAD OF PRINT EUROPCR
Early safety and feasibility of a first-in-class biomimetic transcatheter aortic valve (DurAVR)
FREE ARTICLE - Susheel K. Kodali et al
May 19, 2023
AHEAD OF PRINT EUROPCR
TAVI for bicuspid aortic valves with Evolut platform
FREE ARTICLE - Didier Tchétché et al
May 18, 2023
Coronary
Valvular disease
Heart failure
Peripheral
Hypertension
Stroke